San Diego, Calif – Crown Bioscience, a JSR Life Sciences company, today announced the expansion of their state-of-the-art NGS capabilities, together with the launch of proprietary NGS panel services, providing increased opportunities for pharmaceutical partners to better understand drug mechanisms of action (MOA) and to develop predictive biomarkers for their investigational drug candidates. The newly built, […]
BRANFORD, Conn. — Isoplexis, the leader in single-cell functional proteomics, today announced a $135 million Series D financing comprised of $85 million in equity securities and a $50 million credit facility. The round was led by Perceptive Advisors with participation from other new investors, Ally Bridge Group and funds and accounts managed by BlackRock, as well as other existing investors. IsoPlexis will […]
NanoString’s GeoMx Digital Spatial Profiler Highlighted as a Versatile Platform for High Plex Spatial Analysis of RNA and Protein SEATTLE– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the journal Nature Methods has selected spatially-resolved transcriptomics as their prestigious Method of the Year for 2020. […]
SEATTLE — TwinStrand Biosciences, Inc., a next-generation DNA sequencing technology company, announced today that Gary Gilliland, M.D., Ph.D., has been appointed to its Board of Directors as the company’s fifth board member. Dr. Gilliland brings over 30 years of clinical and research leadership experience, most recently serving as president and director of the Seattle-based Fred Hutchinson Cancer Research Center […]
Proprietary in Situ Single-Cell Omics Technology Speeds Drug & Biomarker Discovery Vizgen, a life sciences company developing the next generation of in situ single-cell genomics, today announced the launch of its Pharma Accelerator Lab in response to high demand from leading pharmaceutical companies who are increasingly turning to single-cell and spatial transcriptomics solutions to accelerate […]
– ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf – ScaleReady’s mission is to make the business of cell and gene therapy practical and viable by providing the most simple, scalable and versatile manufacturing platform in the industry – ScaleReady will provide sales, marketing, and application support for customers globally ScaleReady, a joint venture […]
With support from the Centers for Disease Control and Prevention (CDC), Illumina and Helix have already identified more than 50 cases of the new variant in the US SAN DIEGO–Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel […]
MENLO PARK, CA LevitasBio, a life science tools leader in label-free sample enrichment for cellular analysis, today announced the closing of its $18 million Series B financing round, led by Thalys Medical and joined by Series A lead investor Decheng Capital. The company is the manufacturer of the LeviCell – the world’s first label-free […]
On January 4, 2021, Analytical BioSciences, a single-cell genomics and discovery company, launched OmniBrowser™, a comprehensively curated single cell data compendium with visualization and analysis capabilities that further empower innovative drug discovery and development. “Single cell genomics is becoming a cornerstone for drug discovery and development, clinical diagnosis and scientific research. I hope that OmniBrowser™ […]
WALTHAM, Mass. — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex’s product offering will enable Thermo […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
